| 1 |
Gao D, Zheng CC, Hao JP, Yang CC, Hu CY. Icariin ameliorates behavioral deficits and neuropathology in a mouse model of multiple sclerosis. Brain Res 2023;1804:148267. [PMID: 36731819 DOI: 10.1016/j.brainres.2023.148267] [Reference Citation Analysis]
|
| 2 |
Ning K, Gao R. Icariin protects cerebral neural cells from ischemia‑reperfusion injury in an in vitro model by lowering ROS production and intracellular calcium concentration. Exp Ther Med 2023;25:151. [PMID: 36911386 DOI: 10.3892/etm.2023.11849] [Reference Citation Analysis]
|
| 3 |
Zhang C, Xue P, Zhang H, Tan C, Zhao S, Li X, Sun L, Zheng H, Wang J, Zhang B, Lang W. Gut brain interaction theory reveals gut microbiota mediated neurogenesis and traditional Chinese medicine research strategies. Front Cell Infect Microbiol 2022;12:1072341. [PMID: 36569198 DOI: 10.3389/fcimb.2022.1072341] [Reference Citation Analysis]
|
| 4 |
You M, Yuan P, Li L, Xu H. HIF-1 signalling pathway was identified as a potential new pathway for Icariin’s treatment against Alzheimer’s disease based on preclinical evidence and bioinformatics. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1066819] [Reference Citation Analysis]
|
| 5 |
Tan W, Qi L, Hu X, Tan Z. Research progress in traditional Chinese medicine in the treatment of Alzheimer's disease and related dementias. Front Pharmacol 2022;13:921794. [PMID: 36506569 DOI: 10.3389/fphar.2022.921794] [Reference Citation Analysis]
|
| 6 |
Zhang SY, Zhao J, Ni JJ, Li H, Quan ZZ, Qing H. Application and prospects of high-throughput screening for in vitro neurogenesis. World J Stem Cells 2022;14:393-419. [PMID: 35949394 DOI: 10.4252/wjsc.v14.i6.393] [Reference Citation Analysis]
|
| 7 |
Wang ZB, Wang ZT, Sun Y, Tan L, Yu JT. The future of stem cell therapies of Alzheimer's disease. Ageing Res Rev 2022;:101655. [PMID: 35660003 DOI: 10.1016/j.arr.2022.101655] [Reference Citation Analysis]
|
| 8 |
Wang J, Kong L, Guo RB, He SY, Liu XZ, Zhang L, Liu Y, Yu Y, Li XT, Cheng L. Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer's disease. Drug Deliv 2022;29:1648-62. [PMID: 35616263 DOI: 10.1080/10717544.2022.2072543] [Reference Citation Analysis]
|
| 9 |
Yang W, Han YH, Wang HC, Lu CT, Yu XC, Zhao YZ. Intradermal injection of icariin-HP-β-cyclodextrin improved traumatic brain injury via the trigeminal epineurium-brain dura pathway. J Drug Target 2022;:1-12. [PMID: 35023434 DOI: 10.1080/1061186X.2021.2023159] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
